Browse

Poster Abstracts

B001

OTOLARYNGOLOGY RESIDENT SUPRACLAVICULAR, SUBMENTAL, AND OTHER REGIONAL FLAP EXPOSURE IN THE UNITED STATES

Clinical Research

Andrew T Day, MD1, Liyang Tang, BS1, Jeremy D Richmon, MD2, Urjeet A Patel, MD3, Kevin S Emerick, MD2

1Johns Hopkins Medical Institutions, 2Massachusetts Eye and Ear Infirmary, 3Northwestern University


B002

PATIENT RISK FACTORS AND POSTOPERATIVE COMPLICATIONS MOST ASSOCIATED WITH INCREASING LENGTH OF HOSPITAL STAY FOLLOWING FREE FLAP RECONSTRUCTION OF THE HEAD AND NECK

Clinical Research

Sana H Siddiqui, BA, Aparna Govindan, BA, Dominick V Congiusta, BS, MPH, Jean Anderson Eloy, MD, Soly Baredes, MD, Richard Chan W Park, MD

Rutgers New Jersey Medical School


B003

USABILITY OF ADVANCED PNEUMATIC COMPRESSION FOR THE TREATMENT OF HEAD AND NECK LYMPHEDEMA RELATED TO CANCER

Clinical Research

Harvey N Mayrovitz, PhD1, Shelly Ryan, PT, CLT, LANA, STAR2

1Nova Southeastern University, 2Mercy Hospital


B004

SURVIVAL PROGNOSTIC FACTORS OF METACHRONOUS SECOND PRIMARY HEAD AND NECK SQUAMOUS CELL CARCINOMA

Clinical Research

Szu-Yuan Wu, MD, MPH1, Tsung-Ming Chen, MD2

1Department of Radiation Oncology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, 2Department of Otolaryngology, Shuang-Ho Hospital, Taipei Medical University


B005

IMPACT OF NODAL LEVEL DISTRIBUTION ON SURVIVAL IN PAROTID GLAND SQUAMOUS CELL CARCINOMA: A POPULATION BASED STUDY

Clinical Research

Kajal P Shah, BS, Grace C Iparraguirre, BA, Jacob S Brady, BA, Neil V Nadpara, BA, Tapan Patel, MD, Jean A Eloy, MD, Soly Baredes, MD, Richard Chan W Park, MD

Rutgers New Jersey Medical School


B006

INDEPENDENT OF PRE-TREATMENT WEIGHT LOSS, SURVIVAL IS INCREASED IN PATIENTS DEVELOPING SEVERE WEIGHT LOSS DURING CONCOMMITANT CHEMOTHERAPY AND RADIATION THERAPY FOR ADVANCED OPERABLE SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

Clinical Research

Casey G Sheck, DO, Shawn Shaikh, BS, Mckenzie Montana, BS, Jessica Tyrrell, Michael A Davis, DO, Danielle Tamburrini, DO, Gus Slotman, MD

Inspira Health Network


B007

ENTRECTINIB, A HIGHLY POTENT, BRAIN-PENETRANT PAN-TRK, ROS1, AND ALK INHIBITOR, IS EFFICACIOUS IN MOLECULARLY DEFINED HEAD AND NECK CANCERS

Clinical Research

Alan L Ho, MD, PhD1, Ge Wei, PhD2, Robert Shoemaker, PhD2, David Luo2, Edna Chow Maneval, PhD2, Pratik Multani, MD2, Jason Christiansen, PhD2, Zachary Hornby2, Gary Li, PhD2, Alexander Drilon, MD1

1Memorial Sloan Kettering Cancer Center, 2Ignyta, Inc.


B009

ANGIOSARCOMA OF THE SCALP AND FACE: PATTERNS OF METASTASIS, AND EFFECTS OF SURGICAL INTERVENTION

Clinical Research

Christoph M Prummer, MD, Jeffrey R Janus, MD

Mayo Clinic Rochester


B010

METASTATIC LYMPH NODE BURDEN AND SURVIVAL IN HEAD AND NECK CANCER

Clinical Research

Allen S Ho, MD, Sungjin Kim, MS, Mourad Tighiouart, PhD, Cynthia Gudino, Alain Mita, MD, Kevin Scher, MD, Ravi Prasad, MD, Stephen L Shiao, MD, PhD, Nabilah Ali, Chrysanta Patio, Zachary S Zumsteg, MD

Cedars-Sinai Medical Center